- •Foreword
- •Preface
- •Contents
- •1.1 Introduction
- •1.2 Method
- •1.2.1 Databases
- •1.2.2 Dates
- •1.2.3 Keywords
- •1.2.4 Criteria for Inclusion
- •1.2.5 Criteria for Exclusion
- •1.2.6 Selection of Papers
- •1.3 Results
- •1.3.1 Subspecialty
- •1.3.2 Type of Telemedicine
- •1.3.3 Study Design
- •1.3.4 Final Conclusions of Papers
- •1.4 Discussion
- •References
- •2.1 Introduction
- •2.2 The Need for Diabetic Retinopathy Screening Programs
- •2.4 Guidelines for Referring Patients
- •2.7 Program Models for Diabetic Retinopathy Screening
- •2.9 Program Personnel and Operations
- •2.9.1 Primary Care Providers
- •2.9.2 Photographers
- •2.9.3 Clinical Consultants
- •2.9.4 Administrators
- •2.9.5 A Note to CEOs, Operations Directors, and Clinic Managers
- •2.10 Policies and Procedures
- •2.10.1 Sample Protocol 1
- •2.10.1.1 Diabetic Retinopathy Screening Services
- •Policy
- •Background
- •Procedure
- •2.10.2 Sample Protocol 2
- •2.10.2.1 Pupil Dilation Before Diabetic Retinopathy Photography
- •Policy
- •Background
- •Procedure
- •2.10.3 Sample Protocol 3
- •2.10.3.1 Diabetic Retinopathy Photography Review
- •Policy
- •Background
- •Procedure
- •2.11 Technical Requirements
- •2.11.1 Connectivity
- •2.11.2 Resolution
- •2.11.3 Color
- •2.11.4 Stereopsis
- •2.11.5 Compression
- •2.11.6 Enhancement
- •2.11.7 Pupil Dilation
- •2.11.8 Early California Telemedicine Initiatives Diabetic Retinopathy Screening
- •2.11.9 The American Indian Diabetes Teleophthalmology Grant Program
- •2.11.10 Central Valley EyePACS Diabetic Retinopathy Screening Project
- •2.12.1 Diabetic Retinopathy
- •2.12.1.1 ADA Guidelines Terms
- •2.12.1.2 Vitrectomy
- •References
- •3: Stereopsis and Teleophthalmology
- •3.1 Introduction
- •3.2 History of Stereopsis and Stereopsis in Ophthalmology
- •3.3 Technology and Photography
- •3.3.3 Imaging Fields
- •3.3.4 Image Viewing Techniques
- •3.3.5 Image Compression
- •3.4 Stereoscopic Teleophthalmology Systems
- •3.4.1 University of Alberta
- •3.4.4 Joslin Vision Network
- •3.5 Conclusion
- •References
- •4.1 Introduction
- •4.2 Methods
- •4.2.1 Main Outcome Measures
- •4.3 Results
- •4.3.1 Retinal Video Recording Versus Retinal Still Photography
- •4.3.2 Video Compression Analysis
- •4.4 Discussion
- •References
- •5.1 Introduction
- •5.1.1 Automated, Remote Image Analysis of Retinal Diseases
- •5.1.2 Telehealth
- •5.2 Design Requirements
- •5.2.1 Telehealth Network Architecture
- •5.2.2 Work Flow
- •5.2.3 Performance Evaluation of the Network
- •5.3 Automated Image Analysis Overview
- •5.3.1 Quality Assessment Module
- •5.3.2 Vascular Tree Segmentation
- •5.3.3 Quality Evaluation
- •5.4 Anatomic Structure Segmentation
- •5.4.1 Optic Nerve Detection
- •5.4.2 Macula
- •5.4.3 Lesion Segmentation
- •5.4.4 Lesion Population Description
- •5.4.5 Image Query
- •5.5 Summary
- •References
- •6.1 Introduction
- •6.3 Optical Coherence Tomography to Detect Leakage
- •References
- •7.1 Introduction
- •7.2 Patients and Methods
- •7.2.1 Participants
- •7.2.2 Methods
- •7.2.3 Statistics
- •7.3 Results
- •7.3.1 Reliability of Image Evaluation
- •7.3.2 Prevalence of Glaucomatous Optic Nerve Atrophy
- •7.4 Discussion
- •7.5 Perspectives
- •References
- •8.1 Introduction
- •8.1.2 Homology Between Retinal and Systemic Microvasculature
- •8.1.3 Need for More Precise CVD Risk Prediction
- •8.2.1 Retinal Microvascular Signs
- •8.2.2 Retinal Vessel Biometry
- •8.2.3 Newer Retinal Imaging for Morphologic Features of Retinal Vasculature
- •8.3 Associations of Retinal Imaging and CVD Risk
- •8.3.1.1 Risk of Pre-clinical CVD
- •8.3.1.2 Risk of Stroke
- •8.3.1.3 Risk of Coronary Heart Disease
- •8.3.2.1 Risk of Hypertension
- •8.3.2.2 Risk of Stroke
- •8.3.2.3 Risk of Coronary Heart Disease
- •8.3.2.4 Risk of Peripheral Artery Disease
- •8.3.3 Newer Morphologic Features of Retinal Vasculature
- •8.4 Retinal Imaging and Its Potential as a Tool for CVD Risk Prediction
- •References
- •9.1 Alzheimer’s Disease
- •9.2 Treatments
- •9.3 Diagnosis
- •9.6 Conclusions
- •References
- •10.1 Introduction
- •10.1.1 Stroke
- •10.1.2 Heart Disease
- •10.1.3 Arteriovenous Ratio
- •10.2 Purpose
- •10.3 Method
- •10.3.1 Medical Approach
- •10.3.2 Technical Approach
- •10.3.3 Output of Medical Data
- •10.4 Patients
- •10.5 Results
- •10.5.1 Medical History
- •10.5.2 Telemedical Evaluation of Retinal Vessels
- •10.5.2.1 Prevalence of Retinal Microangiopathy
- •10.5.2.2 Arteriovenous Ratio
- •10.5.2.3 PROCAM-Index
- •10.6 Discussion and Perceptive
- •10.6.1 Estimation of “Stroke Risk” Estimated by the Stage of Retinal Microangiopathy
- •References
- •11.1 Introduction
- •11.2 System Requirements
- •11.3 Fundus Camera
- •11.4 Imaging Procedure
- •11.4.1 Reading Center Procedure
- •11.5 Detection of Macular Edema
- •11.6 Implementation
- •11.7 Unreadable Images
- •11.7.1 Impact on Overall Diabetic Retinopathy Assessment Rates
- •11.7.2 Compliance with Recommendations
- •11.7.3 Challenges
- •11.7.4 Summary
- •References
- •12.1 Screening
- •12.2 Background
- •12.3 Historical Perspective in England
- •12.4 Methodology
- •12.4.1 The Aim of the Programme
- •12.5 Systematic DR Screening
- •12.6 Cameras for Use in the English Screening Programme
- •12.7 Software for Use in the English Screening Programme
- •12.9 Implementation in England
- •12.11 Quality Assurance
- •12.12 The Development of External Quality Assurance in the English Screening Programme
- •12.13 Information Technology (IT) Developments for the English Screening Programme
- •12.14 Dataset Development
- •12.15 The Development of External Quality Assurance Test Set for the English Screening Programme
- •12.16 Failsafe
- •12.17 The Epidemic of Diabetes
- •References
- •13.1 Introduction
- •13.2 Burden of Diabetes and Diabetic Retinopathy in India
- •13.3 Diabetic Retinopathy Screening Models
- •13.4 Need for Telescreening
- •13.5 Guidelines for Telescreening
- •13.6 ATA Categories of DR Telescreening Validation
- •13.7 Yield of Diabetic Retinopathy in a Telescreening Model
- •13.8 How Are Images Transferred
- •13.10 How Many Fields Are Enough for Diabetic Retinopathy Screening
- •13.11 Is Mydriasis Needed While Using Nonmydriatic Camera?
- •13.12 Validation Studies on Telescreening
- •13.12.1 Accuracy of Telescreening
- •13.12.2 Patient Satisfaction in Telescreening
- •13.12.3 Cost Effectivity
- •13.12.4 Telescreening for Diabetic Retinopathy: Our Experience
- •13.13 Future of Diabetic Retinopathy Screening
- •References
- •14.1 Introduction
- •14.2 Methods
- •14.3 Discussion
- •14.4 Conclusion
- •References
- •15.1 Introduction
- •15.1.1 Description of the EADRSI
- •15.5 State Support of Screening in the Safety Net
- •15.7 Screening Economics for Providers
- •15.8 Patient Sensitivity to Fees
- •15.9 Conclusion
- •References
- •16.1 Introduction
- •16.2 Setting Up the New Screening Model
- •16.2.1 Phase 1: Training
- •16.2.2 Phase 2: Evaluation of Agreement
- •16.2.3 Phase 3: Implementation of the Screening Model
- •16.3 Technologic Requirements
- •16.3.1 Data Management
- •16.3.2 Data Models
- •16.3.2.1 Data Scheme for Patient-Related Information
- •16.3.2.2 Data Scheme for Images
- •Fundus Camera VISUCAM Pro NM
- •PACS Server
- •ClearCanvas DICOM Visualizer
- •16.4 Results
- •16.4.1 Phase 2: Agreement Evaluation
- •16.4.2 Phase 3: Implementation of the Screening Model
- •16.5 Discussion
- •16.5.1 Evaluation of the Screening Model
- •16.5.2 Prevalence of DR
- •16.5.3 Quality Evaluation
- •16.6 Conclusion
- •References
- •17.1.3 Examination and Treatment
- •17.1.4 Limitations of Current Care
- •17.2 Telemedicine and ROP
- •17.2.2 Accuracy and Reliability of Telemedicine for ROP Diagnosis
- •17.2.3 Operational ROP Telemedicine Systems
- •17.2.4 Potential Barriers
- •17.3 Closing Remarks
- •17.3.1 Future Directions
- •References
- •18.1 Introduction
- •18.2 Neonatal Stress and Pain
- •18.3 ROP Screening Technique
- •18.4 Effect of Different Examination Techniques on Stress
- •18.5 Future of Retinal Imaging in Babies
- •References
- •19.1 Introduction
- •19.2 History of the Program
- •19.3 Telehealth Technologies
- •19.4 Impact of the Program
- •Selected References
- •Preamble
- •Introduction
- •Background
- •The Diabetic Retinopathy Study (DRS)
- •Mission
- •Vision
- •Goals
- •Guiding Principles
- •Ethics
- •Clinical Validation
- •Category 1
- •Category 2
- •Category 3
- •Category 4
- •Communication
- •Medical Care Supervision
- •Patient Care Coordinator
- •Image Acquisition
- •Image Review and Evaluation
- •Information Systems
- •Interoperability
- •Image Acquisition
- •Compression
- •Data Communication and Transmission
- •Computer Display
- •Archiving and Retrieval
- •Security
- •Reliability and Redundancy
- •Documentation
- •Image Analysis
- •Legal Requirements
- •Facility Accreditation
- •Privileging and Credentialing
- •Stark Act and Self-referrals
- •State Medical Practice Acts/Licensure
- •Tort Liability
- •Duty
- •Standards of Care
- •Consent
- •Quality Control
- •Operations
- •Customer Support
- •Originating Site
- •Transmission
- •Distant Site
- •Financial Factors
- •Reimbursement
- •Grants
- •Federal Programs
- •Other Financial Factors
- •Equipment Cost
- •Summary
- •Abbreviations
- •Appendices
- •Appendix A: Interoperability
- •Appendix B: DICOM Metadata
- •Appendix C: Computer-Aided Detection
- •Appendix D: Health Insurance Portability and Accountability Act (HIPAA)
- •Appendix F: Quality Control
- •Appendix H: Customer Support
- •Level 1
- •Level 2
- •Level 3
- •Appendix I: Reimbursement
- •Medicare
- •Medicaid
- •Commercial Insurance Carrier Reimbursement
- •Other Financial Factors
- •Disease Prevention
- •Resource Utilization
- •American Telemedicine Association’s Telehealth Practice Recommendations for Diabetic Retinopathy
- •Conclusion
- •References
- •Contributors
- •Second Edition
- •First Edition
- •Index
72 |
G. Michelson et al. |
|
|
We Þtted an exact logistic regression model using age group and family history of glaucoma as predictor variables. The parameter estimates for family history and the interaction term were not signiÞcantly different from zero (p > 0.5 for both parameters).
7.4Discussion
A screening examination of ÒhealthyÓ feeling subjects was successfully performed to identify glaucoma at an early stage. The screening was purely focused on the morphology of the optic nerve head. We used a telemedical approach with non-mydriatic fundus cameras.
The telemedical evaluation has had a good reliability with an intraobserver reliability of 0.884 and an interobserver reliability of 0.740.
In the presented study, the appearance of the optic nerve head was evaluated by monoscopic fundus images of 45¡ acquired by telemedical approach using expert assessment. Stereoscopic fundus images would allow more reliable results, but a stereoscopic fundus camera was not applicable as we intended to avoid pharmacological dilatation of the pupil.
Several articles in the literature discussed the prevalence of different forms of glaucoma and glaucomatous optic nerve atrophy [15]. Among Caucasians, open-angle glaucoma (OAG) was the most common form, which led to a comparison of the prevalences of OAG among Caucasians from other studies with the prevalence of glaucoma disease obtained by our study. A meta-analysis of several studies on prevalence of OAG was given by the Eye Diseases Prevalence Research Group [16]. Prevalences of OAG among Whites reported in this meta-analysis are listed in Table 7.2. These prevalences were estimated from pooled data of the Baltimore Eye Survey [17], the Blue Mountains Eye Study [18], the Beaver Dam Study [19], the Rotterdam Study [3], and the Melbourne Visual Impairment Project [6].
A full diagnosis of open-angle glaucoma requires an evaluation of the optic nerve head and visual Þeld testing. In the mentioned studies, the diagnosis of OAG was based on optic nerve appearance and visual Þeld defects. Therefore,
|
|
|
|
|
|
|
|
Female |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Logistic regression |
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
||||
|
0.020 |
|
|
|
|
Moving average |
|
|
|
|
|||
|
|
|
|
|
Metaanalysis by the eye diseases |
|
|||||||
|
|
|
|
|
|
|
|||||||
Prevalence |
|
|
|
|
|
prevalence research group |
|
|
|||||
0.010 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0.000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
45 |
50 |
55 |
60 |
65 |
||||||||
|
|
|
|
|
|
|
|
Age |
|
|
|
|
|
Fig 7.3 The logistic regression model illustrating the inßuence of age on the prevalence of glaucomatous optic nerve atrophy for women
we emphasize that the reported prevalences of OAG are not comparable to our results, which can serve as estimates of the prevalences of glaucomatous atrophy of the optic nerve head, the main sign of OAG. Furthermore, we point out that our selection process differs from the mentioned studies, and we admit that selection on a Þrst-come, Þrst-serve basis leaves room for unknown bias.
Age is a well-known risk factor for glaucoma. We conÞrmed this with our results, which show that the risk of glaucomatous optic nerve atrophy arises with age (see Fig. 7.2).
Two logistic regression models illustrate the inßuence of age on prevalence of glaucomatous optic nerve atrophy separated for women and men. Figure 7.3 shows the logistic regression model of women. In consideration of the small number of cases, we computed the exact logistic regression (p <0.01 in both cases). The exactness of Þt of the logistic regression model is illustrated by a moving average with bandwidth of 5 years. Prevalence of OAG in the meta-analysis [16] was higher than that of glaucomatous optic nerve atrophy. Although this is especially true for women, we could not verify a statistically signiÞcant difference between men and women with respect to the prevalence of glaucomatous optic nerve atrophy.
Compared with other recent studies, our study has a high number of participants (9,602 participants; Rotterdam Study: n = 6,281; Melbourne
7 Tele-glaucoma: Experiences and Perspectives |
73 |
|
|
Visual Impairment Project: n = 3,265; and Reykjavik Eye Study: n = 1,045).
Telemedical evaluation after standardized recording of retinal images allowed a fast and efÞcient screening procedure allowing high-volume screening. Furthermore, physicians are independent of examination time and place, as results are made available to them in a fast and reliable way via secure Internet.
The data of our tele-glaucoma study allow the comparison of the prevalence of glaucomatous optic nerve atrophy among a working population in Germany with the prevalence of OAG among Caucasian populations reported in other studies. The data in our study do not necessarily reßect the true prevalence of glaucoma in Germany. We found a prevalence of glaucomatous optic nerve head atrophy of about 0.36% in our study population.
The medical goal to decrease the incidence of blindness caused by glaucoma by early detection and examination of persons suffering from glaucomatous optic nerve atrophy can be attained by telemedical screening examinations of color images of the retina and the papilla. Ophthalmologic diagnosis of images of the papilla via telemedical techniques is a simple examination method, which allows the identiÞcation of persons with raised glaucoma risk by combination of standardized analysis of the optic nerve head with collection of anamnestic data. The application of modern telemedical communication technology allows examination of more than 100 persons per day and ensures continuous quality control of all medical steps.
7.5Perspectives
In our study, the evaluation of fundus images to diagnose glaucomatous optic nerve atrophy was strongly standardized. The results were based purely on the appearance of the optic nerve head using standardized criteria. Nevertheless, the evaluation is open to subjective bias. To alleviate this drawback in future works, the usage of automated pattern recognition techniques is appropriate. Our group [20] proposed a novel pattern recognition approach to glaucoma detection
Input: Color image optic nerve head
Automated evaluation
Output: Probability of glaucoma and size of optic nerve head in [mm²]
Calculated values |
|
glaucoma risk index |
0.9 |
Papilla size |
2.2 |
Accept Cancel
Fig. 7.4 Scheme of automated glaucoma detection using color fundus images
operating on color fundus images. In a preprocessing step, the system removed features from the image not directly related to glaucoma, e.g., variations in illumination or different locations of the optic nerve head, as well as unimportant retinal structures. Then pixel intensities and two types of coefÞcients describing the preprocessed imageÕs global and spatial frequency information were transformed to lower-dimensional spaces via principal component analysis (PCA). Afterward, the glaucoma probabilities for these features were estimated by support vector machines (SVM) in a Þrst classiÞcation step. In a second step, the probabilities were combined by an additional probabilistic SVM calculating the novel Glaucoma Risk Index (GRI) (see Fig. 7.4).
74 |
G. Michelson et al. |
|
|
Fig. 7.5 Receiver operating characteristic (ROC) curves for detecting glaucoma by an automated procedure
True positive rate
1 |
|
|
|
|
|
|
|
|
|
|
0.8 |
|
|
|
|
|
|
|
|
|
|
0.6 |
|
|
|
|
|
|
|
|
|
|
0.4 |
|
|
|
|
|
|
|
|
|
|
0.2 |
|
|
|
|
|
|
|
GRI |
|
|
|
|
|
|
|
|
|
fraw |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ffft |
|
|
|
|
|
|
|
|
|
|
fsplipe |
|
|
0 |
|
|
|
|
|
0.6 |
0.7 |
0.8 |
0.9 |
1 |
0 |
0.1 |
0.2 |
0.3 |
0.4 |
0.5 |
False positive rate
On a sample set consisting of 575 fundus images, Þvefold cross validation leads to a classiÞcation accuracy of 80%. The resulting area under the ROC curve (AUC) of 88% is competitive with the established topography-based glaucoma probability score of confocal scanning laser tomography, which is 87% (see Fig. 7.5).
The novel Glaucoma Risk Index (GRI) enabled a reliable detection performance based on relatively low-cost color fundus images which is comparable to more expensive traditional methods. Thus, this automated approach might lead to a Þrst, objective, low-cost glaucoma diagnosis followed by more elaborate clinical examinations only if necessary.
References
1. Quigley HA (1996) Number of people with glaucoma worldwide. Br J Ophthalmol 80:389Ð393
2.Johnson GJ, Quigley HA (2003) The glaucomas. In: Johnson GJ, Minassian DC, Weale RA, West SK
(eds) The epidemiology of eye disease. Oxford University Press, New York, pp 222Ð239
3. Wolfs RCW, Borger PH, Ramrattan RS, Klaver CCW, Hulsmann CAA, Hofmann A et al (2000) Changing views on open-angle glaucoma: deÞnitions and prevalences Ð the Rotterdam Study. Invest Ophthalmol Vis Sci 41(11):3309Ð3321
4. Rotchford AP, Kirwan JF, Muller MA, Johnson GJ, Roux P (2003) Temba glaucoma study: a population-based
cross-sectional survey in urban South Africa. Ophthalmology 110(2):376Ð382
5.Ramakrishnan R, Nirmalan PK, Krishnadas R, Thulasiraj RD, Tielsch JM, Katz J et al (2003) Glaucoma in a rural population of southern India: the Aravind comprehensive eye survey. Ophthalmology 110(8):1484Ð1490
6.Wensor MD, McCarthy CA, Stanislavsky YL,
Livingston PM, Taylor HR (1998) The prevalence of glaucoma in the Melbourne Visual Impairment Project. Ophthalmology 105(4):733Ð739
7. Varma R, Ying-Lai M, Francis BA, Nguyen BB, Deneen J, Wilson MR et al (2004) Prevalence of openangle glaucoma and ocular hypertension in Latinos: the Los Angeles Latino Eye Study. Ophthalmology 111(8):1439Ð1448
8. Weih LM, Nanjan M, McCarthy CA, Taylor HR (2001) Prevalence and predictors of open-angle glaucoma: results from the visual impairment project. Ophthalmology 108(11):1966Ð1972
9. Grehn F, Stamper R (eds) (2004) Glaucoma. Springer, Berlin/Heidelberg
10.Michelson G, Striebel W, Prihoda W, Schmidt V (2000) Telemedicine in the control of intra-ocular pressure. J Telemed Telecare 6(Suppl 1):126Ð128
11.Michelson G (2005) TalkingEyes-and-more. Biomed Tech (Berl) 50(7Ð8):218Ð226
12.Jonas J (1989) Biomorphometrie des nervus opticus. Enke, Stuttgart
13.R Development Core Team (2006) A language and
environment for statistical computing. R Foundation for Statistical Computing, Vienna
14. Cox DR (1970) Analysis of binary data. Chapman and Hall, New York
15.Jonasson F, Damji KF, Arnarsson A, Sverrisson T, Wang L, Sasaki H et al (2003) Prevalence of openangle glaucoma in Iceland: Reykjavik Eye Study. Eye (Lond) 17(6):747Ð753
7 Tele-glaucoma: Experiences and Perspectives |
75 |
|
|
16.Friedman DS, Wolfs RC, OÕColmain BJ, Klein BE, Taylor HR, West S et al (2004) Prevalence of open-angle glaucoma among adults in the United
States. Arch Ophthalmol 122(4):532Ð538
17. Tielsch JM, Sommer A, Katz J, Royall RM, Quigley HA, Javitt J (1991) Racial variations in the prevalence of primary open-angle glaucoma. The Baltimore Eye Survey. JAMA 266(3):369Ð374
18. Mitchell P, Smith W, Attebo K, Healey PR (1996) Prevalence of open-angle glaucoma in Australia. The
Blue Mountains Eye Study. Ophthalmology 103(10): 1661Ð1669
19. Klein BE, Klein R, Sponsel WE, Franke T, Cantor LB, Martone J et al (1992) Prevalence of glaucoma. The Beaver Dam Study. Ophthalmology 99(10): 1499Ð1504
20. Bock R, Meier J, L‡szl— GN, Hornegger J, Michelson G (2010) Glaucoma risk index: automated glaucoma detection from color fundus images. Med Image Anal 14:471Ð481
